中药治疗慢性瘙痒的系统评价与Meta分析
与西药相比,中药可降低VAS和DLQI评分、提高有效率;与中西药联用相比,联用组同样在VAS、DLQI和有效率上更优,不良事件无显著差异。
要点
- 中药单用或联用西药在改善慢性瘙痒VAS、DLQI及有效率方面优于西药治疗。
- 中药与西药不良事件发生率无显著差异。
- 证据质量多为低至中等,需高质量研究验证结论。
核心结论
- 中药单用或联合西药治疗慢性瘙痒的疗效优于西药治疗,且不良事件无显著差异。
- 现有高质量研究较少,结论需高质量研究进一步验证。
研究设计与样本
- 纳入比较中药或中药联合西药与西药治疗慢性瘙痒的RCT,用Cochrane工具评估偏倚风险,RevMan 5.3进行Meta分析。
主要发现
- 与安慰剂相比,1项中等质量研究显示中药降低VAS(MD: -2.08;95% CI = -2.34至-1.82)。
- 与中药联用西药相比,16项研究显示降低VAS,4项研究显示降低DLQI(MD = -2.37,95% CI = -2.61至-2.13),13项研究显示提高有效率(RR: 1.28;95% CI = 1.21-1.36)。
- 中药与西药治疗的不良事件发生率无显著差异。
关键数值与推荐
- 与中药联用西药相比,降低DLQI的MD = -2.37(95% CI = -2.61至-2.13),提高有效率的RR: 1.28(95% CI = 1.21-1.36)。
- 与安慰剂相比,中药降低VAS的MD: -2.08(95% CI = -2.34至-1.82)。
临床怎么用
- 临床可考虑将中药单用或联合西药用于慢性瘙痒患者,以改善瘙痒程度和生活质量。
- 使用中药时需关注不良事件,尽管现有研究报告与西药无显著差异。
局限性
- 仅少数高质量研究可用,整体证据质量低至中等。
- 结论需更多高质量随机对照试验验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background: Chronic pruritus (CP) is a common and aggravating symptom associated with skin and systemic diseases. Although clinical reports suggest that Chinese herbal medicine (CHM) is safe and effective in Chronic pruritus treatment, evidence to prove it is lacking. Therefore, in this review, we evaluated the therapeutic effects and safety of Chinese herbal medicine for the treatment of Chronic pruritus. Methods: Nine databases were searched for relevant randomized controlled trials (RCTs) from the inception of the database to 20 April 2022. The randomized controlled trials that compared the treatment of Chinese herbal medicine or a combination of Chinese herbal medicine and conventional western medicine treatment (WM) with western medicine treatment intervention for patients with Chronic pruritus were selected. We evaluated the effects of treatment with Chinese herbal medicine on the degree of pruritus, the Dermatology Life Quality Index (DLQI) score, response rate, recurrence rate, and incidence of adverse events in patients with Chronic pruritus. The risk of bias in each trial was evaluated using the Cochrane Collaboration tool. The RevMan software (version 5.3) was used for performing meta-analyses to determine the comparative effects. Results: Twenty-four randomized controlled trials were included, compared with placebo, moderate-quality evidence from one study showed that Chinese herbal medicine was associated with reduced visual analogue scale (VAS) (MD: -2.08; 95% CI = -2.34 to -1.82). Compared with western medicine treatment, low-to moderate-quality evidence from 8 studies indicated that Chinese herbal medicine was associated with reduced visual analogue scale, 4 studies indicated that Chinese herbal medicine was associated with reduced Dermatology Life Quality Index (MD = -1.80, 95% CI = -2.98 to -.62), and 7 studies indicated that Chinese herbal medicine was associated with improved Effective rate (RR: 1.26; 95% CI = 1.19-1.34). Compared with combination of Chinese herbal medicine and western medicine treatment, 16 studies indicated that Chinese herbal medicine was associated with reduced visual analogue scale, 4 studies indicated that Chinese herbal medicine was associated with reduced Dermatology Life Quality Index (MD = -2.37, 95% CI = -2.61 to -2.13), and 13 studies indicated that Chinese herbal medicine was associated with improved Effective rate (RR: 1.28; 95% CI = 1.21-1.36). No significant difference in the occurrence of adverse events in using Chinese herbal medicine or western medicine treatment was reported. Conclusion: The efficacy of Chinese herbal medicine used with or without western medicine treatment was better than western medicine treatment in treating chronic pruritus. However, only a few good studies are available regarding Chronic pruritus, and thus, high-quality studies are necessary to validate the conclusions of this study.
引用
- Wang J, Chen Y, Yang X, et al. Efficacy and safety of Chinese herbal medicine in the treatment of chronic pruritus: A systematic review and meta-analysis of randomized controlled trials. Front Pharmacol. 2023. PMID: 36712693. doi:10.3389/fphar.2022.1029949
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。